Cell Cryopreservation and Formulation System

What is the Cell Cryopreservation and Formulation System?

A cell cryopreservation and formulation system mixes cells with cryoprotectant and freezes them at a controlled rate. It provides reproducible, fully closed formulation of the final cell therapy dose for long-term storage.

Overview

A cell cryopreservation and formulation system prepares the final dose and freezes it without damaging the cells. Cells are first concentrated to the target dose and mixed with a cryoprotectant, commonly dimethyl sulfoxide, under controlled temperature and mixing so that the additive is distributed evenly and exposure time is limited. The formulated product is transferred into freezing bags or vials through a closed path, then cooled at a defined rate, usually about one degree Celsius per minute, in a controlled-rate freezer or a passive freezing device validated for the container. The system records formulation volumes, cryoprotectant concentration, cooling profile and timing, which are critical for batch consistency. Post-thaw viability and recovery are checked as release tests, and the equipment supports the low-temperature chain that follows.

How does it work?

Cell processing equipment manipulates living cells while preserving viability and function. Separation and selection use immunomagnetic beads or density gradients to enrich a target population. Activation with antibodies or cytokines prepares T cells or other lymphocytes for expansion, which is then carried out in closed, gas-permeable culture systems with controlled temperature, dissolved oxygen and feeding. Washing and concentration use centrifugation in a closed chamber or tangential flow filtration to remove medium, beads and impurities and to reach a defined dose volume. Formulation adds a cryoprotectant such as dimethyl sulfoxide before controlled-rate freezing stores the product at low temperature. Because the product is living and often autologous, the equipment is designed for closed processing, single-use fluid paths, low shear and full traceability of each patient batch.

What are the key features?

• Controlled mixing of cells with cryoprotectant
• Closed transfer into freezing bags or vials
• Controlled-rate freezing at about 1 degree Celsius per minute
• Passive freezing device option validated for container
• Recording of formulation and cooling profile

What are the technical specifications?

A typical cell cryopreservation and formulation system configuration offers cooling rate of 0.1–10 °C/min, typically 1 °C/min, temperature range of Ambient to −80 °C, formulation volume of 5–500 mL, cryoprotectant of DMSO or DMSO-free, user defined, mixing control of Controlled stir or in-line mixing and container formats of Freezing bags, cryovials. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The Cell Cryopreservation and Formulation System is used in cell therapy dose formulation, cryopreservation of expanded cells, stem cell banking and research cell freezing. Across the wider Cell Processing class, laboratories also deploy it for autologous cell therapy manufacturing, allogeneic cell product manufacturing and CAR-T and TCR cell production.

Which standards and certifications apply?

Relevant standards and methods include EU GMP Annex 1, EU GMP Annex 11, 21 CFR Part 11, 21 CFR Part 1271, ISO 13485, USP <1046> and IEC 61010-1. Certification candidates for this model are CE, ISO 13485 manufacturing and IEC 61010-1 compliance; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Handle all materials under the appropriate biosafety and cleanroom conditions, and use aseptic technique throughout. Verify that reagents and consumables are qualified for the process and that lot changes are controlled. Confirm closed-system integrity, especially connectors and welds, and monitor cell counts, viability and sterility at defined points. Programmable steps should be locked and version controlled, and each patient or batch record should capture operator, reagents and deviations. Maintain temperature control and check that shear and centrifugation settings do not reduce viability. For regulated production, validate the process, qualify the equipment and confirm that software meets data integrity requirements. Electrical safety follows IEC 61010-1.

How do I select the right Cell Cryopreservation and Formulation System?

Choose a cryopreservation and formulation system when dose accuracy and reproducible freezing matter. In an RFQ specify formulation volume, cryoprotectant and concentration control, cooling rate range and profile, container formats, closedness and the batch record features needed.

How does it compare with other Cell Processing variants?

Select equipment from the cell type, the target dose and the closedness your product requires. Autologous therapies need single-use, closed fluid paths that avoid open manipulation, so specify bag and connector formats and whether processing is manual, semi-automated or fully automated. For selection, choose immunomagnetic or density-based methods according to the required purity, recovery and whether the target is rare. For expansion, match the culture surface area, gas exchange and feeding strategy to the expected fold expansion and cell density. For washing and concentration, define the final dose volume, acceptable recovery and whether a cryoprotectant must be added in the same closed circuit. Confirm traceability, batch records and validation support, and check that the system fits your cleanroom grade and operator workflow.